Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing.
Esophagus
Fundoplication, contrast agent
Magnetic resonance imaging
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
26
07
2020
accepted:
23
03
2021
revised:
17
02
2021
pubmed:
25
4
2021
medline:
21
10
2021
entrez:
24
4
2021
Statut:
ppublish
Résumé
To evaluate image quality by first use of LumiVision® in dynamic MR swallowing, a contrast medium consisting of biological substances versus a gadolinium-buttermilk mixture in patients who underwent Nissen fundoplication due to gastroesophageal reflux disease (GERD). The protocol of this retrospective study was approved by the local Institutional Review Board. A hundred twenty-nine patients (146 examinations) underwent a dynamic MR swallowing study (at 1.5 T or 3.0 T) and received an oral contrast agent. Two readers evaluated the distention of the esophagus, contrast, and traceability of the bolus in a 3-point scale. A steady-state coherent sequence (B-FFE, TrueFISP) was used. The patients were divided into 3 different groups: 53 patients received gadolinium chelate (Dotarem®)-buttermilk mixture (GBM) in a dilution of 1:40 as an oral contrast agent; 44 patients received LumiVision® water mixture (LWM) in a dilution of 1:1 and 49 patients received LumiVision® (L) undiluted. GBM showed significantly better results in overall evaluation for both readers in contrast to LWM (p = .003, p = .002). L also reached significantly better results in overall evaluation than LWM in both readers (p = .004, p = .042). There was no significant difference in the overall evaluation between L and GBM (p = .914, p = .376).According to Landis and Koch, interobserver agreement was "substantial" (Cohen's kappa = 0.738) between both readers. LumiVision® undiluted showed equal image quality compared to gadolinium-buttermilk mixture. The constellation of LumiVision® water mixture led to a clearly negative result in relation to the image quality compared to LumiVision® undiluted. Therefore, oral ingestion of LumiVision® undiluted is recommended for MR swallowing examinations. • LumiVision® undiluted shows significantly better image quality in comparison to LumiVision® diluted in oral application in swallowing MRI. • LumiVision® undiluted shows equal image quality in comparison to gadolinium-buttermilk mixture in oral application. • Oral ingestion of LumiVision® undiluted can replace gadolinium-buttermilk mixture in oral MR examinations.
Identifiants
pubmed: 33893856
doi: 10.1007/s00330-021-07927-5
pii: 10.1007/s00330-021-07927-5
pmc: PMC8523424
doi:
Substances chimiques
Contrast Media
0
Gadolinium DTPA
K2I13DR72L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8578-8585Informations de copyright
© 2021. The Author(s).
Références
Br J Clin Pharmacol. 2018 Nov;84(11):2522-2534
pubmed: 30032482
Eur Radiol. 2019 Sep;29(9):4691-4698
pubmed: 30805702
J Comput Assist Tomogr. 2009 Sep-Oct;33(5):666-71
pubmed: 19820489
Eur Radiol. 2019 Aug;29(8):4400-4407
pubmed: 30421012
Abdom Imaging. 2012 Jun;37(3):447-56
pubmed: 21630051
Eur Radiol. 2002 Jan;12(1):129-33
pubmed: 11868088
Eur Radiol. 2012 Feb;22(2):364-70
pubmed: 21894565
Sci Rep. 2015 Jul 15;5:12112
pubmed: 26175205
Dentomaxillofac Radiol. 2015;44(8):20150028
pubmed: 26090932
J Comput Assist Tomogr. 2004 Sep-Oct;28(5):697-703
pubmed: 15480047
BMC Med Imaging. 2014 Sep 22;14:33
pubmed: 25245815
Magn Reson Imaging. 2006 Feb;24(2):195-200
pubmed: 16455409
AJR Am J Roentgenol. 1984 Mar;142(3):619-24
pubmed: 6607655
Eur J Radiol. 2018 Jul;104:14-19
pubmed: 29857860
Invest Radiol. 2000 Dec;35(12):707-11
pubmed: 11204796
J Magn Reson Imaging. 2007 Apr;25(4):749-54
pubmed: 17340641
Eur Radiol. 2014 Sep;24(9):2137-45
pubmed: 24965508
Europace. 2017 Aug 1;19(8):1310-1316
pubmed: 27915264
Radiol Med. 2006 Oct;111(7):881-9
pubmed: 17021694
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
AJR Am J Roentgenol. 2014 Nov;203(5):1001-5
pubmed: 25341137
Eur Radiol. 2019 Dec;29(12):6653-6661
pubmed: 31187219